JADBio

JADBio is a Copenhagen-based AI company offering a no-code AutoML platform designed to simplify and accelerate biomarker discovery and predictive modeling from complex, multi-omics data. Its technology, validated by publications in high-impact journals like Nature and Cell Press, targets applications across oncology, chronic diseases, infectious diseases, and mental health. The company operates a B2B platform-as-a-service model, partnering with biotech firms and research organizations to enhance drug discovery and diagnostic development.

No-code Automated Machine Learning (AutoML) platform specialized for multi-omics data (genomics, transcriptomics, proteomics, metabolomics, etc.). It automates the full ML pipeline with a strong emphasis on interpretable biomarker discovery and feature selection to build predictive models for healthcare outcomes.

JADBio competes in the AI-for-drug-discovery space against large cloud providers (e.g., Google, Amazon) offering general-purpose AutoML, as well as specialized bioinformatics software companies and a growing number of AI-native biotech startups. Its differentiation lies in its dedicated focus on multi-omics, its emphasis on interpretable feature selection for biomarker discovery, and its no-code interface tailored for life science researchers.